Publications Database

Fisman S. , Steele M. (1996)

Use of risperidone in pervasive developmental disorders: a case series.

Journal of Child and Adolescent Psychopharmacology

Fall, 6(3), pp. 177-190.

Read Abstract (New Window)

Gagliano A. et al. (2004)

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 39-47

Read Abstract (New Window)

Gencer O. et al. (2008)

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder : An open label maintenance study.

European Child and Adolescent Psychiatry

17(4), pp. 217-225

Read Abstract (New Window)

Ghaeli . P. et al. (2014)

Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study.

Indian Journal of Psychological Medicine

36(1), pp. 66-70.

Read Abstract (New Window) Read Full (New Window)

Ghaleiha A. et al. (2015)

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

Psychiatry Research

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.

Journal of Psychopharmacology

October, 28(7), pp. 677-685.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

International Journal of Neuropsycholpharmacology

16(4), pp. 783-789.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: A double-blind, placebo-controlled, randomized trial.

Pediatric Drugs

15(6), pp. 505-514.

Read Abstract (New Window)

Ghanizadeh A. , Sahraeizadeh A. , Berk M. (2014)

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.

Child Psychiatry and Human Development

45(2), pp. 185-192.

Read Abstract (New Window)

Ghanizadeh A. , Moghimi-Sarani E. (2013)

A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders.

BMC Psychiatry

13(1), pp. 196.

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. (2009)

Does risperidone improve hyperacusia in children with autism?

Psychopharmacology Bulletin

42(1), pp. 108-110

Read Abstract (New Window)

Hammock R. , Levine W. R. , Schroeder S. R. (2001)

Brief report: Effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation.

Journal of Autism and Developmental Disorders

31(1), pp. 109-113

Read Abstract (New Window)

Hazell P. (2007)

Drug therapy for attention-deficit hyperactivity disorder-like symptoms in autistic disorder.

Journal of Paediatrics and Child Health

43(1), pp. 19-24

Read Abstract (New Window)

Hellings J. A. et al. (2006)

A crossover study of risperidone in children, adolescents and adults with mental retardation.

Journal of Autism and Developmental Disorders

36(3), pp. 401-411

Read Abstract (New Window)

Hellings J. A. et al. (2001)

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 229-238

Read Abstract (New Window)

Hergüner S. , Mukaddes N. M. (2007)

Risperidone-induced enuresis in two children with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

17(4), pp. 527-530.

Read Abstract (New Window)

Hirota T. et al. (2014)

Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis.

Journal of Autism and Developmental Disorders

44(4), pp. 948-957.

Read Abstract (New Window)

Hongkaew Y. et al. (2015)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone.

Neuropsychiatric Disease and Treatment

11 pp. 191-196.

Read Abstract (New Window) Read Full (New Window)

Horrigan J. , Barnhill L. (1997)

Risperidone and explosive aggressive autism.

Journal of Autism and Developmental Disorders

27(3), pp. 313-323

Read Abstract (New Window)

Hughes D. M. , Libretto S. E. , Cunningham M. M. (2002)

Risperidone in children and adolescents with autistic disorder and aggressive behaviour.

British Journal of Developmental Disabilities

July, 48(95), pp. 113-122.

Read Abstract (New Window)